DE68903882T2 - Immunochemisches testverfahren fuer humanen granulozyten-makrophagen-kolonie stimulierenden faktor. - Google Patents

Immunochemisches testverfahren fuer humanen granulozyten-makrophagen-kolonie stimulierenden faktor.

Info

Publication number
DE68903882T2
DE68903882T2 DE8989305175T DE68903882T DE68903882T2 DE 68903882 T2 DE68903882 T2 DE 68903882T2 DE 8989305175 T DE8989305175 T DE 8989305175T DE 68903882 T DE68903882 T DE 68903882T DE 68903882 T2 DE68903882 T2 DE 68903882T2
Authority
DE
Germany
Prior art keywords
antibody
csf
human
monoclonal antibody
monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989305175T
Other languages
German (de)
English (en)
Other versions
DE68903882D1 (de
Inventor
John S Abrams
Dyke Robert E Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering Biotech Corp
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of DE68903882D1 publication Critical patent/DE68903882D1/de
Application granted granted Critical
Publication of DE68903882T2 publication Critical patent/DE68903882T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8989305175T 1988-05-31 1989-05-23 Immunochemisches testverfahren fuer humanen granulozyten-makrophagen-kolonie stimulierenden faktor. Expired - Fee Related DE68903882T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/201,068 US5070013A (en) 1988-05-31 1988-05-31 Immunochemical assay for human granulocyte-macrophage colony stimulating factor

Publications (2)

Publication Number Publication Date
DE68903882D1 DE68903882D1 (de) 1993-01-28
DE68903882T2 true DE68903882T2 (de) 1993-04-22

Family

ID=22744353

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989305175T Expired - Fee Related DE68903882T2 (de) 1988-05-31 1989-05-23 Immunochemisches testverfahren fuer humanen granulozyten-makrophagen-kolonie stimulierenden faktor.

Country Status (10)

Country Link
US (1) US5070013A (https=)
EP (2) EP0422037A1 (https=)
JP (1) JPH0768277B2 (https=)
AT (1) ATE83490T1 (https=)
AU (1) AU3744289A (https=)
DE (1) DE68903882T2 (https=)
ES (1) ES2052913T3 (https=)
GR (1) GR3007000T3 (https=)
HK (1) HK6196A (https=)
WO (1) WO1989012108A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468774A3 (en) * 2005-04-18 2013-01-02 Amgen Research (Munich) GmbH Antibody neutralizers of human granulocyte macrophage colony stimulating factor
US20100255513A1 (en) * 2007-03-30 2010-10-07 Denson Lee A Serological markers of inflammatory bowel disease phenotype and disease progression
TW200918553A (en) 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
JP2013505968A (ja) * 2009-10-01 2013-02-21 シーエスエル、リミテッド フィラデルフィア染色体陽性白血病の治療方法
EP2914289B1 (en) 2012-10-31 2019-05-22 Takeda GmbH Lyophilized formulation comprising gm-csf neutralizing compound
AR093297A1 (es) 2012-10-31 2015-05-27 Amgen Res Munich Gmbh Formulacion liquida que comprende un compuesto neutralizante de gm-csf
US10745475B2 (en) 2013-08-30 2020-08-18 Takeda Gmbh Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics
WO2023110942A1 (en) * 2021-12-14 2023-06-22 Charité-Universitätsmedizin Berlin Prevention of impaired fracture healing
CN120399067B (zh) * 2025-07-02 2025-09-30 武汉伊莱瑞特生物科技股份有限公司 一种与人gm-csf特异性结合的单克隆抗体及其检测试剂盒和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
DE3382317D1 (de) * 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4562003A (en) * 1984-10-26 1985-12-31 California Biotechnology, Inc. Monoclonal antibodies against alveolar surfactant protein
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
GB8624899D0 (en) * 1986-10-17 1986-11-19 Sandoz Ltd Monoclonal antibodies
US4851341A (en) * 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system

Also Published As

Publication number Publication date
JPH03502523A (ja) 1991-06-13
GR3007000T3 (https=) 1993-06-30
DE68903882D1 (de) 1993-01-28
JPH0768277B2 (ja) 1995-07-26
ES2052913T3 (es) 1994-07-16
HK6196A (en) 1996-01-19
WO1989012108A1 (en) 1989-12-14
ATE83490T1 (de) 1993-01-15
EP0344957A1 (en) 1989-12-06
EP0422037A1 (en) 1991-04-17
US5070013A (en) 1991-12-03
EP0344957B1 (en) 1992-12-16
AU3744289A (en) 1990-01-05

Similar Documents

Publication Publication Date Title
DE3382764T2 (de) Humane-humane hybridomas für neoplasmen.
DE69132045T2 (de) Monoklonale Antikörper gegen menschlichen Tumornekrosefaktor alpha
DE60019111T2 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
DE3587507T2 (de) Monoklonale antikörper gegen alveolares oberflächenaktives protein.
DE68925935T2 (de) Antikörper gegen Interleukin-1-beta
EP0260610A2 (de) Monoklonale Antikörper gegen humanen Tumonekrosefaktor (TNF) und deren Verwendung
DE68903882T2 (de) Immunochemisches testverfahren fuer humanen granulozyten-makrophagen-kolonie stimulierenden faktor.
DE3873877T2 (de) Bestimmung von monokinen.
DE3942999C2 (de) Verfahren zum Nachweis von malignen Erkrankungen
DE3218312C2 (de) Monoklonale Antikörper, Hybridoma-Zellklone, Verfahren zu ihrer Herstellung und ihre Verwendung zur Erkennung von Brustkrebs und maligner Lymphogranulomatose
DE69028095T2 (de) M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen
DE69033457T2 (de) Prohormonspaltungsplatzblockierungsantikörper
DE69635715T2 (de) Monoklonaler antikoerper spezifisch fuer prostaglandin d synthetase
DE3900650A1 (de) Vitamin-b12-bestimmung
DE69434024T2 (de) Auf humanen cortikalen thymozyten exprimierte oberflächenproteine und ihre verwendung
DE3785567T2 (de) Immunologischer testkit.
DE68922846T2 (de) Enzymimmuntest für menschliches typiv-collagen gemäss dem sandwichverfahren.
EP0854152B1 (de) Antikörper und immunoassay zum Nachweis von MIA
DE3650635T2 (de) Monoklonale Antikörper
DE3851855T2 (de) Gegen die Gamma-Kette des T-Zell-Rezeptors gerichteter monoklonaler Antikörper.
WO2003040185A2 (de) Anti-n-glykolyl-neuraminsäure-antikörper und ihre verwendung zur bestimmung von glykoproteinen
DE69114361T2 (de) Monoklonaler Antikörper, der Membran-Phopholipase A2 erkennt und Immuntest für Membran-Phospholipase A2.
EP0193880B1 (de) Verfahren und Reagenz zur Bestimmung des Follikel stimulierenden Hormons sowie hierzu geeignete monoklonale Antikörper
DE60014616T2 (de) Antikörper gegen plazentaprotein 13
DE69735760T2 (de) Antikörper gegen menschliches lect2, zellen die diesen produzieren und verfahren und kit zu dessen bestimmung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee